15-00-2024
The Polish startup IQ Biozoom is gaining international recognition for its groundbreaking technology in metabolic health. Highlighted by The Recursive as a leading innovator in Central Europe, IQ Biozoom is developing a non-invasive device for monitoring biomarkers like glucose, lactates, cholesterol, and hormones. This technology, utilizing advanced biosensors produced with stream printing and thin-film transistors, aims to replace traditional, invasive testing methods.
Launched in Stalowa Wola, IQ Biozoom is recognized by the European network Hello Tomorrow as one of the world's most promising startups. Their device can analyze biomarkers from various bodily fluids, including saliva, sweat, tears, and urine, providing a more comfortable and precise alternative to finger-prick tests.
The company's collaboration with Krakow’s LifeScience Cluster and its innovative approach have positioned it as a key player in the medtech field. The technology's potential to enhance home diagnostics is significant, particularly for individuals managing chronic conditions such as diabetes. The startup is preparing for further investment and development to bring this advanced diagnostic tool to the market.
For more information, you can read the full article here (https://pro.rp.pl/start-upy-2024-pot-i-lzy-pacjenci-to-docenia).
IQ Biozoom introduces revolutionary medical innovations with its biosensing platform. We develop non-invasive, pain-free saliva-based tests to monitor various civilisation diseases, providing easy access to health information.
Get more info about IQ Biozoom Technology
Interesting in our science publications? Contact us to get the links.
Meet us:
